Literature DB >> 9472369

Why are some doctors high-prescribers of benzodiazepines and minor opiates? A qualitative study of GPs in Norway.

T B Dybwad1, L Kjølsrød, J Eskerud, E Laerum.   

Abstract

BACKGROUND: Registration studies have shown great variations in prescribing volume and prescribing patterns of benzodiazepines (BZDs) and minor opiates among GPs.
OBJECTIVES: We aimed to form a basis for hypotheses and build theories about prescribing, in order to investigate how high-prescribing doctors can legitimize their own prescribing pattern.
METHODS: A qualitative interview study of doctors with previously known high, medium and low prescribing volumes was performed. The interpretation focused on the doctors' self-explanations and how they influence their daily decision of prescribing. RESULTS AND
CONCLUSIONS: It was a striking feature that many of the attitudes towards the drugs were common both within and between the three groups of prescribers. All doctors regarded the task of prescribing as difficult, and the great majority strongly advocated restriction in prescribing. In order to cope with daily practice and to live with high prescribing volumes, doctors make use of effective working strategies. These strategies, of ascribing responsibility to the previous doctor, to patient autonomy and responsibility, to the patient's age and to concomitant diseases, are described in this study. An allocation of responsibility to other persons or circumstances delimits the doctors' professional discretion in this matter. Striking differences between prescriber groups were not found in the analysis, but when all small tendencies in all steps of the decision-making process were added, a clear trend was revealed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9472369     DOI: 10.1093/fampra/14.5.361

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  16 in total

1.  Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway.

Authors:  Svein R Kjosavik; Sabine Ruths; Steinar Hunskaar
Journal:  Eur J Clin Pharmacol       Date:  2011-09-18       Impact factor: 2.953

2.  Patients' and clinicians' experiences and perceptions of the primary care management of insomnia: qualitative study.

Authors:  Zowie Davy; Jo Middlemass; Aloysius N Siriwardena
Journal:  Health Expect       Date:  2013-08-19       Impact factor: 3.377

3.  Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.

Authors:  Carina Lundby; Trine Graabaek; Jesper Ryg; Jens Søndergaard; Anton Pottegård; Dorthe Susanne Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-02-27       Impact factor: 4.335

4.  Prescription of benzodiazepines in Slovenian family medicine: a qualitative study.

Authors:  Maja Subelj; Gaj Vidmar; Vesna Svab
Journal:  Wien Klin Wochenschr       Date:  2010-07-28       Impact factor: 1.704

5.  A qualitative comparative investigation of variation in general practitioners' prescribing patterns.

Authors:  Chrys Jaye; Murray Tilyard
Journal:  Br J Gen Pract       Date:  2002-05       Impact factor: 5.386

6.  Perceptions of benzodiazepine dependence among women age 65 and older.

Authors:  Sarah L Canham; Joseph Gallo; Linda Simoni-Wastila
Journal:  J Gerontol Soc Work       Date:  2014-09-24

7.  The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives.

Authors:  Sibyl Anthierens; Hilde Habraken; Mirko Petrovic; Thierry Christiaens
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

8.  Narcotic analgesic utilization amongst injured workers: using concept mapping to understand current issues from the perspectives of physicians and pharmacists.

Authors:  Janet A Parsons; Muhammad Mamdani; Onil Bhattacharyya; Claire Marie Fortin; Magda Melo; Christina Salmon; Stavroula R Raptis; Donna Bain; Patricia O'Campo
Journal:  BMC Health Serv Res       Date:  2011-10-20       Impact factor: 2.655

9.  "It could potentially be dangerous... but nothing else has seemed to help me.": Patient and clinician perspectives on benzodiazepine use in opioid agonist treatment.

Authors:  Tae Woo Park; Jennifer Sikov; Vanessa dellaBitta; Richard Saitz; Alexander Y Walley; Mari-Lynn Drainoni
Journal:  J Subst Abuse Treat       Date:  2021-04-30

10.  A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing.

Authors:  Ingunn Fride Tvete; Trine Bjørner; Ivar Andreas Aursnes; Tor Skomedal
Journal:  BMJ Open       Date:  2013-10-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.